2017
DOI: 10.18203/2349-3933.ijam20173715
|View full text |Cite
|
Sign up to set email alerts
|

To study the carotid intima media thickness in patients of fatty liver disease

Abstract: Background: Fatty liver is associated with several atherosclerotic risk factors such as hypertension, diabetes and dyslipidemia. It has also been related to insulin resistance. This association was found in NIDDM patients as well as in non-diabetic subjects. An increased intima-media thickness (IMT) has been shown to be a risk factor for myocardial infarction and stroke. The aim of the present study is to investigate associations between hepatic steatosis and the risk of atherosclerosis.Methods: The present st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 14 publications
(14 reference statements)
0
1
0
Order By: Relevance
“…(Lundqvist et al, 1999) An augmented IMT has been shown to be a risk factor for myocardial infarction and stroke. In addition, carotid ultrasound has been a precise diagnostic tool to determine atherosclerotic plaques and to assess the degree of luminal narrowing secondary to atherosclerotic changes of the vessel wall (Chouhan et al, 2017). NAFLD has clinical, laboratory and pathological circumstances ranged from mild steatosis nonalcoholic steatohepatitis (NASH) to liver diseases such as ibrosis, cirrhosis and eventually hepatocellular carcinoma (Clark et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…(Lundqvist et al, 1999) An augmented IMT has been shown to be a risk factor for myocardial infarction and stroke. In addition, carotid ultrasound has been a precise diagnostic tool to determine atherosclerotic plaques and to assess the degree of luminal narrowing secondary to atherosclerotic changes of the vessel wall (Chouhan et al, 2017). NAFLD has clinical, laboratory and pathological circumstances ranged from mild steatosis nonalcoholic steatohepatitis (NASH) to liver diseases such as ibrosis, cirrhosis and eventually hepatocellular carcinoma (Clark et al, 2003).…”
Section: Introductionmentioning
confidence: 99%